1. Home
  2. NTST vs ARVN Comparison

NTST vs ARVN Comparison

Compare NTST & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTST
    SELLHOLDBUYas of 21 hours ago
  • ARVN
    SELLHOLDBUYas of 21 hours ago
  • Stock Information
  • Founded
  • NTST 2019
  • ARVN 2015
  • Country
  • NTST United States
  • ARVN United States
  • Employees
  • NTST N/A
  • ARVN N/A
  • Industry
  • NTST Real Estate Investment Trusts
  • ARVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTST Real Estate
  • ARVN Health Care
  • Exchange
  • NTST Nasdaq
  • ARVN Nasdaq
  • Market Cap
  • NTST 1.2B
  • ARVN 1.2B
  • IPO Year
  • NTST 2020
  • ARVN 2018
  • Fundamental
  • Price
  • NTST $15.86
  • ARVN $7.02
  • Analyst Decision
  • NTST Strong Buy
  • ARVN Buy
  • Analyst Count
  • NTST 7
  • ARVN 13
  • Target Price
  • NTST $17.75
  • ARVN $34.42
  • AVG Volume (30 Days)
  • NTST 881.6K
  • ARVN 3.5M
  • Earning Date
  • NTST 04-28-2025
  • ARVN 05-06-2025
  • Dividend Yield
  • NTST 5.29%
  • ARVN N/A
  • EPS Growth
  • NTST N/A
  • ARVN N/A
  • EPS
  • NTST N/A
  • ARVN N/A
  • Revenue
  • NTST $162,784,000.00
  • ARVN $263,399,999.00
  • Revenue This Year
  • NTST $10.40
  • ARVN N/A
  • Revenue Next Year
  • NTST $9.61
  • ARVN $7.99
  • P/E Ratio
  • NTST N/A
  • ARVN N/A
  • Revenue Growth
  • NTST 23.41
  • ARVN 235.54
  • 52 Week Low
  • NTST $13.42
  • ARVN $6.88
  • 52 Week High
  • NTST $18.97
  • ARVN $41.34
  • Technical
  • Relative Strength Index (RSI)
  • NTST 69.03
  • ARVN 23.50
  • Support Level
  • NTST $15.24
  • ARVN $8.51
  • Resistance Level
  • NTST $15.45
  • ARVN $9.17
  • Average True Range (ATR)
  • NTST 0.31
  • ARVN 0.55
  • MACD
  • NTST 0.05
  • ARVN -0.05
  • Stochastic Oscillator
  • NTST 75.59
  • ARVN 5.24

Stock Price Comparison Chart: NTST vs ARVN

NTST
ARVN
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100110NTST VS ARVN

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use